Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Waeber

Showing results (411-420 of 458) with videos related to

Pageof 46
Sort By:
Clinical Pharmacology and Therapeutics|June 1, 1987
Pharmacokinetics of synthetic atrial natriuretic peptides in normal menJ Biollaz, L T Callahan, J Nussberger, et al.
The Journal of Clinical Investigation|August 1, 1987
Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragmentM Schapira, M A Ramus, B Waeber, et al.
European Journal of Biochemistry|June 15, 1992
A novel cyclic analog of neuropeptide Y specific for the Y2 receptorA G Beck-Sickinger, E Grouzmann, E Hoffmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1982
Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive ratsB Waeber, H Gavras, I Gavras, et al.
Lancet (London, England)|September 26, 1987
Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recordingB Waeber, U Scherrer, A Petrillo, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1988
[Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?]J L Ader, B Waeber, J M Suc, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteersM D Schaller, J Nussberger, B Waeber, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1986
Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteersJ Biollaz, J Nussberger, M Porchet, et al.
Kidney International|October 1, 1987
Site of the action of a synthetic atrial natriuretic peptide evaluated in humansJ Biollaz, J Bidiville, J Diézi, et al.
Pageof 46

Showing results (411-420 of 458) with videos related to

Sort By:
Pageof 46
Clinical Pharmacology and Therapeutics|June 1, 1987
Pharmacokinetics of synthetic atrial natriuretic peptides in normal menJ Biollaz, L T Callahan, J Nussberger, et al.
The Journal of Clinical Investigation|August 1, 1987
Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragmentM Schapira, M A Ramus, B Waeber, et al.
European Journal of Biochemistry|June 15, 1992
A novel cyclic analog of neuropeptide Y specific for the Y2 receptorA G Beck-Sickinger, E Grouzmann, E Hoffmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1982
Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive ratsB Waeber, H Gavras, I Gavras, et al.
Lancet (London, England)|September 26, 1987
Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recordingB Waeber, U Scherrer, A Petrillo, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1988
[Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?]J L Ader, B Waeber, J M Suc, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteersM D Schaller, J Nussberger, B Waeber, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1986
Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteersJ Biollaz, J Nussberger, M Porchet, et al.
Kidney International|October 1, 1987
Site of the action of a synthetic atrial natriuretic peptide evaluated in humansJ Biollaz, J Bidiville, J Diézi, et al.
Pageof 46